Loading…
Selective Oestrogen Receptor Agonists Rescued Hippocampus Parameters in Male Spontaneously Hypertensive Rats
Spontaneously hypertensive rats (SHR) show pronounced hippocampus alterations, including low brain‐derived neurotrophic factor (BDNF) expression, reduced neurogenesis, astrogliosis and increased aromatase expression. These changes are reverted by treatment with 17β‐oestradiol. To determine which oes...
Saved in:
Published in: | Journal of neuroendocrinology 2016-10, Vol.28 (10), p.np-n/a |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4245-30670ba6198053de97c3ecf897209b4b385edb7715fae6c606b19b1e412881073 |
---|---|
cites | cdi_FETCH-LOGICAL-c4245-30670ba6198053de97c3ecf897209b4b385edb7715fae6c606b19b1e412881073 |
container_end_page | n/a |
container_issue | 10 |
container_start_page | np |
container_title | Journal of neuroendocrinology |
container_volume | 28 |
creator | Pietranera, L. Correa, J. Brocca, M. E. Roig, P. Lima, A. Di Giorgio, N. Garcia-Segura, L. M. De Nicola, A. F. |
description | Spontaneously hypertensive rats (SHR) show pronounced hippocampus alterations, including low brain‐derived neurotrophic factor (BDNF) expression, reduced neurogenesis, astrogliosis and increased aromatase expression. These changes are reverted by treatment with 17β‐oestradiol. To determine which oestradiol receptor (ER) type is involved in these neuroprotective effects, we used agonists of the ERα [propylpyrazole triol (PPT)] and the ERβ [diarylpropionitrite (DPN)] given over 2 weeks to 4‐month‐old male SHR. Wistar Kyoto normotensive rats served as controls. Using immunocytochemistry, we determined glial fibrillary protein (GFAP)+ astrocytes in the CA1, CA3 and hilus of the dentate gyrus of the hippocampus, aromatase immunostaining in the hilus, and doublecortin (DCX)+ neuronal progenitors in the inner granular zone of the dentate gyrus. Brain‐derived neurotrophic factor mRNA was also measured in the hippocampus by the quantitative polymerase chain reaction. In SHR, PPT had no effect on blood pressure, decreased astrogliosis, slightly increased BDNF mRNA, had no effect on the number of DCX+ progenitors, and increased aromatase staining. Treatment with DPN decreased blood pressure, decreased astrogliosis, increased BDNF mRNA and DCX+ progenitors, and did not modify aromatase staining. We hypothesise that, although both receptor types may participate in the previously reported beneficial effects of 17β‐oestradiol in SHR, receptor activation with DPN may preferentially facilitate BDNF mRNA expression and neurogenesis. The results of the present study may help in the design of ER‐based neuroprotection for the encephalopathy of hypertension. |
doi_str_mv | 10.1111/jne.12415 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1837326750</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4228127231</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4245-30670ba6198053de97c3ecf897209b4b385edb7715fae6c606b19b1e412881073</originalsourceid><addsrcrecordid>eNqNkU1v1DAQhi1ERZfCgT-AInGBQ1qPHX_kWK1Kl1W_1BZxtBzvbJUliVM7Afbf4yVtD5Uq4ctI1jOPZuYl5APQQ0jvaNPhIbACxCsyAy5FzjSTr8mMloLnGspin7yNcUMpKMHpG7LPlABVKD0jzQ026Ib6F2aXGIfg77DLrtFhP_iQHd_5ro5DTD_RjbjKFnXfe2fbfozZlQ22xQFDzOouO7cNZje97wbboR9js80W2x7DgF3c2a_tEN-RvbVtIr5_qAfk-9eT2_kiP7s8_TY_PstdwQqRcyoVrayEUlPBV1gqx9GtdakYLaui4lrgqlIKxNqidJLKCsoKsACmNVDFD8jnydsHfz-mtUxbR4dNM41mQHPFmVSC_g8qpE63KhP66Rm68WPo0iI7inEhFIVEfZkoF3yMAdemD3Vrw9YANbu0TErL_EsrsR8fjGPV4uqJfIwnAUcT8LtucPuyySwvTh6V-dSRYsM_Tx02_DRScSXMj4tTM79aLvR8CeaW_wX27azs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1832355701</pqid></control><display><type>article</type><title>Selective Oestrogen Receptor Agonists Rescued Hippocampus Parameters in Male Spontaneously Hypertensive Rats</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Pietranera, L. ; Correa, J. ; Brocca, M. E. ; Roig, P. ; Lima, A. ; Di Giorgio, N. ; Garcia-Segura, L. M. ; De Nicola, A. F.</creator><creatorcontrib>Pietranera, L. ; Correa, J. ; Brocca, M. E. ; Roig, P. ; Lima, A. ; Di Giorgio, N. ; Garcia-Segura, L. M. ; De Nicola, A. F.</creatorcontrib><description>Spontaneously hypertensive rats (SHR) show pronounced hippocampus alterations, including low brain‐derived neurotrophic factor (BDNF) expression, reduced neurogenesis, astrogliosis and increased aromatase expression. These changes are reverted by treatment with 17β‐oestradiol. To determine which oestradiol receptor (ER) type is involved in these neuroprotective effects, we used agonists of the ERα [propylpyrazole triol (PPT)] and the ERβ [diarylpropionitrite (DPN)] given over 2 weeks to 4‐month‐old male SHR. Wistar Kyoto normotensive rats served as controls. Using immunocytochemistry, we determined glial fibrillary protein (GFAP)+ astrocytes in the CA1, CA3 and hilus of the dentate gyrus of the hippocampus, aromatase immunostaining in the hilus, and doublecortin (DCX)+ neuronal progenitors in the inner granular zone of the dentate gyrus. Brain‐derived neurotrophic factor mRNA was also measured in the hippocampus by the quantitative polymerase chain reaction. In SHR, PPT had no effect on blood pressure, decreased astrogliosis, slightly increased BDNF mRNA, had no effect on the number of DCX+ progenitors, and increased aromatase staining. Treatment with DPN decreased blood pressure, decreased astrogliosis, increased BDNF mRNA and DCX+ progenitors, and did not modify aromatase staining. We hypothesise that, although both receptor types may participate in the previously reported beneficial effects of 17β‐oestradiol in SHR, receptor activation with DPN may preferentially facilitate BDNF mRNA expression and neurogenesis. The results of the present study may help in the design of ER‐based neuroprotection for the encephalopathy of hypertension.</description><identifier>ISSN: 0953-8194</identifier><identifier>EISSN: 1365-2826</identifier><identifier>DOI: 10.1111/jne.12415</identifier><identifier>PMID: 27517478</identifier><language>eng</language><publisher>United States: Blackwell Publishing Ltd</publisher><subject><![CDATA[Animals ; Aromatase - metabolism ; Astrocytes - drug effects ; Astrocytes - metabolism ; Blood Pressure ; Brain-Derived Neurotrophic Factor - metabolism ; Doublecortin Protein ; Estrogen Receptor alpha - agonists ; Estrogen Receptor alpha - physiology ; Estrogen Receptor beta - agonists ; Estrogen Receptor beta - physiology ; Gliosis ; hippocampus ; Hippocampus - drug effects ; Hippocampus - metabolism ; hypertension ; Male ; Neural Stem Cells - drug effects ; Neural Stem Cells - metabolism ; neurogenesis ; Neurons - drug effects ; Neurons - metabolism ; Nitriles - administration & dosage ; oestrogen receptors ; Organ Size ; Phenols - administration & dosage ; Pituitary Gland - anatomy & histology ; Pituitary Gland - drug effects ; Propionates - administration & dosage ; Pyrazoles - administration & dosage ; Rats, Inbred SHR ; Rats, Inbred WKY ; RNA, Messenger - metabolism ; Testis - anatomy & histology ; Testis - drug effects]]></subject><ispartof>Journal of neuroendocrinology, 2016-10, Vol.28 (10), p.np-n/a</ispartof><rights>2016 British Society for Neuroendocrinology</rights><rights>2016 British Society for Neuroendocrinology.</rights><rights>Copyright © 2016 British Society for Neuroendocrinology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4245-30670ba6198053de97c3ecf897209b4b385edb7715fae6c606b19b1e412881073</citedby><cites>FETCH-LOGICAL-c4245-30670ba6198053de97c3ecf897209b4b385edb7715fae6c606b19b1e412881073</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27517478$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pietranera, L.</creatorcontrib><creatorcontrib>Correa, J.</creatorcontrib><creatorcontrib>Brocca, M. E.</creatorcontrib><creatorcontrib>Roig, P.</creatorcontrib><creatorcontrib>Lima, A.</creatorcontrib><creatorcontrib>Di Giorgio, N.</creatorcontrib><creatorcontrib>Garcia-Segura, L. M.</creatorcontrib><creatorcontrib>De Nicola, A. F.</creatorcontrib><title>Selective Oestrogen Receptor Agonists Rescued Hippocampus Parameters in Male Spontaneously Hypertensive Rats</title><title>Journal of neuroendocrinology</title><addtitle>J Neuroendocrinol</addtitle><description>Spontaneously hypertensive rats (SHR) show pronounced hippocampus alterations, including low brain‐derived neurotrophic factor (BDNF) expression, reduced neurogenesis, astrogliosis and increased aromatase expression. These changes are reverted by treatment with 17β‐oestradiol. To determine which oestradiol receptor (ER) type is involved in these neuroprotective effects, we used agonists of the ERα [propylpyrazole triol (PPT)] and the ERβ [diarylpropionitrite (DPN)] given over 2 weeks to 4‐month‐old male SHR. Wistar Kyoto normotensive rats served as controls. Using immunocytochemistry, we determined glial fibrillary protein (GFAP)+ astrocytes in the CA1, CA3 and hilus of the dentate gyrus of the hippocampus, aromatase immunostaining in the hilus, and doublecortin (DCX)+ neuronal progenitors in the inner granular zone of the dentate gyrus. Brain‐derived neurotrophic factor mRNA was also measured in the hippocampus by the quantitative polymerase chain reaction. In SHR, PPT had no effect on blood pressure, decreased astrogliosis, slightly increased BDNF mRNA, had no effect on the number of DCX+ progenitors, and increased aromatase staining. Treatment with DPN decreased blood pressure, decreased astrogliosis, increased BDNF mRNA and DCX+ progenitors, and did not modify aromatase staining. We hypothesise that, although both receptor types may participate in the previously reported beneficial effects of 17β‐oestradiol in SHR, receptor activation with DPN may preferentially facilitate BDNF mRNA expression and neurogenesis. The results of the present study may help in the design of ER‐based neuroprotection for the encephalopathy of hypertension.</description><subject>Animals</subject><subject>Aromatase - metabolism</subject><subject>Astrocytes - drug effects</subject><subject>Astrocytes - metabolism</subject><subject>Blood Pressure</subject><subject>Brain-Derived Neurotrophic Factor - metabolism</subject><subject>Doublecortin Protein</subject><subject>Estrogen Receptor alpha - agonists</subject><subject>Estrogen Receptor alpha - physiology</subject><subject>Estrogen Receptor beta - agonists</subject><subject>Estrogen Receptor beta - physiology</subject><subject>Gliosis</subject><subject>hippocampus</subject><subject>Hippocampus - drug effects</subject><subject>Hippocampus - metabolism</subject><subject>hypertension</subject><subject>Male</subject><subject>Neural Stem Cells - drug effects</subject><subject>Neural Stem Cells - metabolism</subject><subject>neurogenesis</subject><subject>Neurons - drug effects</subject><subject>Neurons - metabolism</subject><subject>Nitriles - administration & dosage</subject><subject>oestrogen receptors</subject><subject>Organ Size</subject><subject>Phenols - administration & dosage</subject><subject>Pituitary Gland - anatomy & histology</subject><subject>Pituitary Gland - drug effects</subject><subject>Propionates - administration & dosage</subject><subject>Pyrazoles - administration & dosage</subject><subject>Rats, Inbred SHR</subject><subject>Rats, Inbred WKY</subject><subject>RNA, Messenger - metabolism</subject><subject>Testis - anatomy & histology</subject><subject>Testis - drug effects</subject><issn>0953-8194</issn><issn>1365-2826</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNqNkU1v1DAQhi1ERZfCgT-AInGBQ1qPHX_kWK1Kl1W_1BZxtBzvbJUliVM7Afbf4yVtD5Uq4ctI1jOPZuYl5APQQ0jvaNPhIbACxCsyAy5FzjSTr8mMloLnGspin7yNcUMpKMHpG7LPlABVKD0jzQ026Ib6F2aXGIfg77DLrtFhP_iQHd_5ro5DTD_RjbjKFnXfe2fbfozZlQ22xQFDzOouO7cNZje97wbboR9js80W2x7DgF3c2a_tEN-RvbVtIr5_qAfk-9eT2_kiP7s8_TY_PstdwQqRcyoVrayEUlPBV1gqx9GtdakYLaui4lrgqlIKxNqidJLKCsoKsACmNVDFD8jnydsHfz-mtUxbR4dNM41mQHPFmVSC_g8qpE63KhP66Rm68WPo0iI7inEhFIVEfZkoF3yMAdemD3Vrw9YANbu0TErL_EsrsR8fjGPV4uqJfIwnAUcT8LtucPuyySwvTh6V-dSRYsM_Tx02_DRScSXMj4tTM79aLvR8CeaW_wX27azs</recordid><startdate>201610</startdate><enddate>201610</enddate><creator>Pietranera, L.</creator><creator>Correa, J.</creator><creator>Brocca, M. E.</creator><creator>Roig, P.</creator><creator>Lima, A.</creator><creator>Di Giorgio, N.</creator><creator>Garcia-Segura, L. M.</creator><creator>De Nicola, A. F.</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>201610</creationdate><title>Selective Oestrogen Receptor Agonists Rescued Hippocampus Parameters in Male Spontaneously Hypertensive Rats</title><author>Pietranera, L. ; Correa, J. ; Brocca, M. E. ; Roig, P. ; Lima, A. ; Di Giorgio, N. ; Garcia-Segura, L. M. ; De Nicola, A. F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4245-30670ba6198053de97c3ecf897209b4b385edb7715fae6c606b19b1e412881073</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Animals</topic><topic>Aromatase - metabolism</topic><topic>Astrocytes - drug effects</topic><topic>Astrocytes - metabolism</topic><topic>Blood Pressure</topic><topic>Brain-Derived Neurotrophic Factor - metabolism</topic><topic>Doublecortin Protein</topic><topic>Estrogen Receptor alpha - agonists</topic><topic>Estrogen Receptor alpha - physiology</topic><topic>Estrogen Receptor beta - agonists</topic><topic>Estrogen Receptor beta - physiology</topic><topic>Gliosis</topic><topic>hippocampus</topic><topic>Hippocampus - drug effects</topic><topic>Hippocampus - metabolism</topic><topic>hypertension</topic><topic>Male</topic><topic>Neural Stem Cells - drug effects</topic><topic>Neural Stem Cells - metabolism</topic><topic>neurogenesis</topic><topic>Neurons - drug effects</topic><topic>Neurons - metabolism</topic><topic>Nitriles - administration & dosage</topic><topic>oestrogen receptors</topic><topic>Organ Size</topic><topic>Phenols - administration & dosage</topic><topic>Pituitary Gland - anatomy & histology</topic><topic>Pituitary Gland - drug effects</topic><topic>Propionates - administration & dosage</topic><topic>Pyrazoles - administration & dosage</topic><topic>Rats, Inbred SHR</topic><topic>Rats, Inbred WKY</topic><topic>RNA, Messenger - metabolism</topic><topic>Testis - anatomy & histology</topic><topic>Testis - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pietranera, L.</creatorcontrib><creatorcontrib>Correa, J.</creatorcontrib><creatorcontrib>Brocca, M. E.</creatorcontrib><creatorcontrib>Roig, P.</creatorcontrib><creatorcontrib>Lima, A.</creatorcontrib><creatorcontrib>Di Giorgio, N.</creatorcontrib><creatorcontrib>Garcia-Segura, L. M.</creatorcontrib><creatorcontrib>De Nicola, A. F.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of neuroendocrinology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pietranera, L.</au><au>Correa, J.</au><au>Brocca, M. E.</au><au>Roig, P.</au><au>Lima, A.</au><au>Di Giorgio, N.</au><au>Garcia-Segura, L. M.</au><au>De Nicola, A. F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Selective Oestrogen Receptor Agonists Rescued Hippocampus Parameters in Male Spontaneously Hypertensive Rats</atitle><jtitle>Journal of neuroendocrinology</jtitle><addtitle>J Neuroendocrinol</addtitle><date>2016-10</date><risdate>2016</risdate><volume>28</volume><issue>10</issue><spage>np</spage><epage>n/a</epage><pages>np-n/a</pages><issn>0953-8194</issn><eissn>1365-2826</eissn><abstract>Spontaneously hypertensive rats (SHR) show pronounced hippocampus alterations, including low brain‐derived neurotrophic factor (BDNF) expression, reduced neurogenesis, astrogliosis and increased aromatase expression. These changes are reverted by treatment with 17β‐oestradiol. To determine which oestradiol receptor (ER) type is involved in these neuroprotective effects, we used agonists of the ERα [propylpyrazole triol (PPT)] and the ERβ [diarylpropionitrite (DPN)] given over 2 weeks to 4‐month‐old male SHR. Wistar Kyoto normotensive rats served as controls. Using immunocytochemistry, we determined glial fibrillary protein (GFAP)+ astrocytes in the CA1, CA3 and hilus of the dentate gyrus of the hippocampus, aromatase immunostaining in the hilus, and doublecortin (DCX)+ neuronal progenitors in the inner granular zone of the dentate gyrus. Brain‐derived neurotrophic factor mRNA was also measured in the hippocampus by the quantitative polymerase chain reaction. In SHR, PPT had no effect on blood pressure, decreased astrogliosis, slightly increased BDNF mRNA, had no effect on the number of DCX+ progenitors, and increased aromatase staining. Treatment with DPN decreased blood pressure, decreased astrogliosis, increased BDNF mRNA and DCX+ progenitors, and did not modify aromatase staining. We hypothesise that, although both receptor types may participate in the previously reported beneficial effects of 17β‐oestradiol in SHR, receptor activation with DPN may preferentially facilitate BDNF mRNA expression and neurogenesis. The results of the present study may help in the design of ER‐based neuroprotection for the encephalopathy of hypertension.</abstract><cop>United States</cop><pub>Blackwell Publishing Ltd</pub><pmid>27517478</pmid><doi>10.1111/jne.12415</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0953-8194 |
ispartof | Journal of neuroendocrinology, 2016-10, Vol.28 (10), p.np-n/a |
issn | 0953-8194 1365-2826 |
language | eng |
recordid | cdi_proquest_miscellaneous_1837326750 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | Animals Aromatase - metabolism Astrocytes - drug effects Astrocytes - metabolism Blood Pressure Brain-Derived Neurotrophic Factor - metabolism Doublecortin Protein Estrogen Receptor alpha - agonists Estrogen Receptor alpha - physiology Estrogen Receptor beta - agonists Estrogen Receptor beta - physiology Gliosis hippocampus Hippocampus - drug effects Hippocampus - metabolism hypertension Male Neural Stem Cells - drug effects Neural Stem Cells - metabolism neurogenesis Neurons - drug effects Neurons - metabolism Nitriles - administration & dosage oestrogen receptors Organ Size Phenols - administration & dosage Pituitary Gland - anatomy & histology Pituitary Gland - drug effects Propionates - administration & dosage Pyrazoles - administration & dosage Rats, Inbred SHR Rats, Inbred WKY RNA, Messenger - metabolism Testis - anatomy & histology Testis - drug effects |
title | Selective Oestrogen Receptor Agonists Rescued Hippocampus Parameters in Male Spontaneously Hypertensive Rats |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T06%3A38%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Selective%20Oestrogen%20Receptor%20Agonists%20Rescued%20Hippocampus%20Parameters%20in%20Male%20Spontaneously%20Hypertensive%20Rats&rft.jtitle=Journal%20of%20neuroendocrinology&rft.au=Pietranera,%20L.&rft.date=2016-10&rft.volume=28&rft.issue=10&rft.spage=np&rft.epage=n/a&rft.pages=np-n/a&rft.issn=0953-8194&rft.eissn=1365-2826&rft_id=info:doi/10.1111/jne.12415&rft_dat=%3Cproquest_cross%3E4228127231%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4245-30670ba6198053de97c3ecf897209b4b385edb7715fae6c606b19b1e412881073%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1832355701&rft_id=info:pmid/27517478&rfr_iscdi=true |